文献速递临床免疫质量管理与危急值

亟需关注传染病抗体检测的质量控制流程

Time to address quality control processes applied to antibody testing for infectious diseases.
PubMed 文献 · Clin Chem Lab Med · 2022-11-09

该文指出传染病血清学检测从手工方法转向高通量自动化分析仪后,传统临床化学质控方法被直接套用,但两者存在诸多差异。血清学检测的是结合强度而非抗体量,且存在批间变异,因此临床化学质控方法不适用。文章概述了这些差异并提出一系列质控建议。

要点

  • 传染病血清学检测的是抗体结合强度而非抗体量,与临床化学检测有本质区别。
  • 所有血清学检测均存在批间变异,直接套用临床化学质控方法不恰当。
  • ISO 15189和世界卫生组织推荐使用第三方质控品,但需最小化批间变异并检测异常变异。

核心结论

  • 临床化学质控方法不适用于传染病血清学检测,需针对其特点制定专门质控流程。

主要发现

  • 传染病血清学检测抗体类别和抗原多变,随病原体基因型/血清型和疾病阶段变化。
  • 血清学检测报告数值(通常为信号与临界值比值),但并非测量抗体量而是检测系统内结合强度。
  • 所有血清学检测均存在批间变异。

关键数值与推荐

  • 许多司法管辖区强制要求使用制造商提供的试剂盒质控品验证检测运行。
  • ISO 15189和世界卫生组织高度推荐使用第三方质控品,其批间变异应最小且能检测异常变异。

临床怎么用

  • 应认识到传染病血清学与临床化学的差异,避免直接套用临床化学质控方法。
  • 考虑使用第三方质控品,并确保其批间变异最小且能检测异常变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As testing for infectious diseases moves from manual, biological testing such as complement fixation to high throughput automated autoanalyzer, the methods for controlling these assays have also changed to reflect those used in clinical chemistry. However, there are many differences between infectious disease serology and clinical chemistry testing, and these differences have not been considered when applying traditional quality control methods to serology. Infectious disease serology, which is highly regulated, detects antibodies of varying classes and to multiple and different antigens that change according to the organisms' genotype/serotype and stage of disease. Although the tests report a numerical value (usually signal to cut-off), they are not measuring an amount of antibodies, but the intensity of binding within the test system. All serology assays experience lot-to-lot variation, making the use of quality control methods used in clinical chemistry inappropriate. In many jurisdictions, the use of the manufacturer-provided kit controls is mandatory to validate the test run. Use of third-party controls, which are highly recommended by ISO 15189 and the World Health Organization, must be manufactured in a manner whereby they have minimal lot-to-lot variation and at a level where they detect exceptional variation. This paper outlines the differences between clinical chemistry and infectious disease serology and offers a range of recommendations when addressing the quality control of infectious disease serology.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Dimech WJ, Vincini GA, Plebani M, et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med. 2022. PMID: 36345644. doi:10.1515/cclm-2022-0986

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。